Search research articles
Contact Us
Filters
Showing results (311-320 of 332) with videos related to
Page
of 34
Sort By:
Journal of Virology
|
August 17, 2006
Phenotype-based identification of host genes required for replication of African swine fever virus
Annie C Y Chang, Laszlo Zsak, Yanan Feng, et al.
Plos One
|
September 26, 2017
Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival
Hervé J Brisse, Thomas Blanc, Gudrun Schleiermacher, et al.
JAMA Oncology
|
October 27, 2022
Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer: The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial
Pierre Loap, Delphine Loirat, Frederique Berger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Accumulation of segmental alterations determines progression in neuroblastoma
Gudrun Schleiermacher, Isabelle Janoueix-Lerosey, Agnès Ribeiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report
Susan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2005
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study
V Oyharcabal-Bourden, C Kalifa, J C Gentet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2010
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project
Veronica Moroz, David Machin, Andreas Faldum, et al.
British Journal of Cancer
|
September 4, 2008
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
B De Bernardi, V Mosseri, H Rubie, et al.
Plos One
|
July 12, 2014
Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN
Anne Guimier, Sandrine Ferrand, Gaëlle Pierron, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 8, 2006
Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study
J Verlooy, V Mosseri, S Bracard, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 332) with videos related to
Sort By:
Page
of 34
Journal of Virology
|
August 17, 2006
Phenotype-based identification of host genes required for replication of African swine fever virus
Annie C Y Chang, Laszlo Zsak, Yanan Feng, et al.
Plos One
|
September 26, 2017
Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival
Hervé J Brisse, Thomas Blanc, Gudrun Schleiermacher, et al.
JAMA Oncology
|
October 27, 2022
Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer: The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial
Pierre Loap, Delphine Loirat, Frederique Berger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Accumulation of segmental alterations determines progression in neuroblastoma
Gudrun Schleiermacher, Isabelle Janoueix-Lerosey, Agnès Ribeiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report
Susan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2005
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study
V Oyharcabal-Bourden, C Kalifa, J C Gentet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2010
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project
Veronica Moroz, David Machin, Andreas Faldum, et al.
British Journal of Cancer
|
September 4, 2008
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
B De Bernardi, V Mosseri, H Rubie, et al.
Plos One
|
July 12, 2014
Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN
Anne Guimier, Sandrine Ferrand, Gaëlle Pierron, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 8, 2006
Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study
J Verlooy, V Mosseri, S Bracard, et al.
Page
of 34